Sputnik-V is considered more effective than Covishield and Covaxin. Russia’s Gamalaya Research Institute claims that Sputnik V is 91.6 percent effective, while Covishield is said to be 80 percent effective and Covaxin is up to 81 percent effective.
Sputnik V vaccine can be found in India in 3-4 weeks. Amid the increasing pace of Corona, late Monday night, the country’s Drug Controller General of India approved Russia’s vaccine Sputnik V for restricted emergency use. It is expected that in the month of June-July, the stock of vaccine will also increase along with the local supply. This vaccine is being said to be more effective than the serum institute and Bharat Biotech vaccine. Its effect on the elderly is also claimed to be better.
Initially there will be import, then it will be manufactured in the country
In India, this vaccine will be imported through Dr Reddy Labs at Sharuat. The government’s negotiations for the purchase of the vaccine are now in the final stages. India will initially import Sputnik V, but later it will be able to be manufactured in the country itself. Currently, a vaccination campaign is being carried out across the country through Covishield and Bharat Biotech’s Covaxin, developed by AstraZeneca and Oxford University in India and produced by the Serum Institute. With the arrival of Sputnik V, the country’s dependence on these two vaccines will be reduced. Currently 70 million shots of both these vaccines are being produced in the country every month.
Claims to be more effective than Covishield and Covaxin.
The Drug Controller General of India gave this approval only after Sputnik V was found completely safe. India is the 60th country in the world to approve this vaccine. Prior to India, this vaccine has been approved in 59 countries around the world. Sputnik-V is considered more effective than Kovishield and Kovaxin. Gamalaya Research Institute of Russia claims that Sputnik V is effective up to 91.6 percent, while Covishield is said to be 80 percent effective and Covaxin is up to 81 percent effective. Its first dose can give 87.6 percent protection. In addition, this vaccine is also said to be very effective for the elderly over 60 years of age.